Verizon has the largest post-paid subscriber base in the U.S., but can it keep growing its digital business and fend off hungry rivals?
Performance of liquid alternatives in 2016 was mediocre, with most indexes up low to mid-single digits. That does not mean investors should give up on the asset class.
Recent all-time highs are near-term hurdles that must be cleared for stock indices to continue pushing higher.
There are several reasons why Celgene should buy Biogen.
The car rental company said they were worried about "creeping control" in a move that comes as an agreement between the company and SRS Investment Management is set to expire.
Investors will focus on the company's full-year guidance.
The combination of the insurance giants was found to be a threat to competition.
Investors who want to hedge against a market pullback may way to buy the precious metal.
President Donald Trump's regulation freeze puts in limbo a rule requiring financial advisers to acts in the best interests' of their clients saving for retirement.
There's not much reason to be bullish on these stocks.
Shares of Bristol-Myers Squibb are higher during trading on Monday, after Jefferies reiterated its 'buy' rating, but analysts are mixed on the call.
Media stocks have been on fire since Trump was elected president, but as the new administration takes office, uncertainties about future policy and economic growth are dampening the sector's outlook.
Tradebird users are bullish on bitcoin and Tesla stock, but they're bearish on the pound and yen.
Check out Jim and TheStreet editorial team’s latest analysis and commentary on what’s moving markets now.